Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
The Phase 3 trials show Tesamorelin reduces VAT by approximately 15-17.5% over 26-52 weeks compared to placebo
Growth Hormone Receptor Upregulation : It has a small but significant effect on increasing growth hormone receptors at injury sites, which may enhance the action of growth hormone involved in tissue turnover and repair 3
- Monitor Injection Site: Keep an eye on the area for redness or swelling and contact us if you notice any unusual reactions
View the Phase 2 retatrutide trial on PubMed
In animal work, BPC-157 has been tied to less gut damage and faster healing in several injury models
US$ 28.82
US$ 27.65
US$ 26.99
US$ 27.58
US$ 28.76
